Botox vs Dysport - IAPAM Expert Discussion

Given the FDA approval of the new botulinum toxin A product, Dysport, in 2009, a competitor to the well establish Botox Cosmetic, the IAPAM recently queried its members and physicians with comprehensive experience in the use of botulinum toxin injectables, to develop a report comparing these two products.  This discussion is considered a critical element in the IAPAM’s comprehensive botox training programs.

Dysport has been studied in Europe since 1988, has been available for use outside the US since 1991, and was recently approved for cosmetic use in the US in May 2009. Equally, Botox has been manufactured and studied in the US since 1985, and was officially approved by the FDA for cosmetic use in April 2002.

Botox ® and Dysport ® are not interchangeable because the products are dosed and injected differently.  To assist physicians in selecting the best product for each patient’s need, a number of physicians have offered their expert comparison of Botox ®Cosmetic and Dysport ®. Read more